首页 | 本学科首页   官方微博 | 高级检索  
     

地奥心血康胶囊治疗冠心病心绞痛Ⅱ期临床试验
引用本文:冯子玉. 地奥心血康胶囊治疗冠心病心绞痛Ⅱ期临床试验[J]. 中国新药与临床杂志, 1994, 0(3)
作者姓名:冯子玉
作者单位:华西医科大学第四附属医院
摘    要:用地奥心血康胶囊治疗冠心病心绞痛患者486例(男性276例,女性210例,年龄60±s8a),分为3组进行双盲对照。02号药物组77例,口服硝酸异山梨酯5mg,tid;04号药物组377例,口服地奥心血康100mg,tid;05号药物组32例,口服复方丹参3片,tid。疗程均为2mo。结果04组疗效87.6%优于02组(66%)及05组(52%),P<0.05。

关 键 词:地奥心血康,硝酸异山梨酯,丹参,皂甙类,心绞痛,Ⅱ期临床试验

Phase Ⅱ clinical trial of Di-ao-xin-xue-kang capsule in treating angina pectoris
FENG Zi-Yu. Phase Ⅱ clinical trial of Di-ao-xin-xue-kang capsule in treating angina pectoris[J]. Chinese Journal of New Drugs and Clinical Remedies, 1994, 0(3)
Authors:FENG Zi-Yu
Abstract:Four hundred and eighty-six patients(M 276,F210;age 60±s 8 a) with angina perctoris were assigned to three groups in a double-blind method.Group 02(n=77) received isosorbide dinitrate 5 mg,po,tid;group 04(n=377) took DAXXK 100 mg,po,tid;group 05(n=32) used Salvia miltiorrhiza 3 pills,po,tid,all for 2 mo,The total effective rates were 66%,87.6%,and 52% respectively.Group 04 was significantly superior to group 02 and group 05(P<0.05).
Keywords:Di-ao-xin-xue-kang  isosorbide dinitrate  Salvia miltiorrhiza  saponins  angina pectoris  phase Ⅱ clinical trials
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号